Orion Pharma

Over 100 years ago, Orion Pharma was founded in Finland. Inspired by our Nordic heritage, we bring over a century of pharmaceutical innovation, with patients at the heart of what we do. 💙 Our R&D pipeline is grounded in decades of rigorous science and drug development, addressing unmet needs for people living with cancer. Today, we are advancing a diverse oncology pipeline of small molecules and biologics, powered by our global R&D team across Finland, the UK and the US. Interested in learning more? Connect with us at #ESMO26. #Oncology #CancerResearch #WeAreOrionPharma #BuildingWellBeing

See you in Spain – Orion Pharma is attending the 2026 ESMO Annual Congress! Curious about our scientific approach to oncology research and what’s new across our R&D pipeline? Meet our R&D and Innovative Medicines teams on the ground at booth 1047 to learn how we are shaping Orion Pharma’s next era of global oncology innovation. 🔬 In 2026, momentum has carried across our investigational R&D oncology portfolio, including: ✅ the start of a Phase 2 trial for TEAD inhibitor ODM-212 ✅ first clinical data from our Phase 1/2 TEADES trial of ODM-212 ✅ dosing the first patient in our Phase 1/2 BICIDES trial with ODM-216, a bispecific antibody targeting PVRIG x PD-L1, our first biologic and first immuno-oncology candidate to enter the clinic Building off 20+ years of innovation in cancer research, our team – Outi Vaarala, Berkeley Vincent, Geula Jaffe, and Praveen Aanur, and more – looks forward to connecting with the global oncology community in Madrid. #ESMO26 #Oncology #CancerResearch #WeAreOrionPharma #BuildingWellBeing

📅 J-30 avant la première édition d’Orion Pharma Park ! Les 6 et 7 novembre, experts, professionnels de santé et acteurs de l’innovation se retrouveront à Paris pour deux journées d’échanges autour de l’intelligence artificielle et de ses applications dans la maladie de Parkinson. 🎥 En vidéo, le Dr Claude MEKIES, neurologue, et le Dr Stéphane OHAYON, médecin et data scientist, vous donnent un aperçu des thématiques qui rythmeront ces rencontres. 📍 6 novembre : Ambassade de Finlande, Paris 📍 7 novembre : Hôtel Pullman Montparnasse, Paris #OrionPharmaPark #Parkinson #IntelligenceArtificielle #Santé

For Orion Pharma, it starts with a question: what could tomorrow's healthcare look like? Together with researchers, healthcare professionals and our partners, we advance science and develop new medicines that have the potential to improve patients’ lives. By bringing knowledge and expertise together, we contribute to stronger healthcare and a healthier future for people and societies. Because building well-being means the world to us. #TheWellbeingJourney #Healthcare #Collaboration #WeAreOrionPharma

For Orion Pharma, it starts with people dedicated to making a real difference for patients in need. We have a long history of developing novel therapies for a wide range of diseases and treatment needs. It takes years of research, setbacks and breakthroughs, but sometimes a discovery in the lab can become a treatment that makes a difference to patients’ lives. That’s what drives our scientists to come to work every day. Because building well-being means the world to us. #TheWellbeingJourney #DrivenByScience #WeAreOrionPharma

For Orion Pharma, it starts with a commitment: patients must have access to the medicines they need, close to home. Through our Nordic-based production of both medicines and active pharmaceutical ingredients, we contribute to European security of supply, helping ensure essential treatments are available for patients in need. Because building well-being means the world to us. #TheWellbeingJourney #SecurityOfSupply #WeAreOrionPharma